INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINE-Reference-Cited by-同舟云学术

INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINE

Published:2000-10 Issue:4 Volume:164 Page:1248-1253
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BERRUTI ALFREDO¹,DOGLIOTTI LUIGI¹,BITOSSI RAFFAELLA¹,FASOLIS GIUSEPPE¹,GORZEGNO GABRIELLA¹,BELLINA MAURIZIO¹,TORTA MIRELLA¹,PORPIGLIA FRANCESCO¹,FONTANA DARIO¹,ANGELI ALBERTO¹

Affiliation:

1. From the Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Clinica Medica, Oncologia Medica e Urologia, Azienda Ospedaliera San Luigi, Orbassano, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference32 articles.

1. Bone Metastases: Diagnosis and Treatment;Rubens,1991

2. The anatomy and pathways of skeletal metastases;Galasko,1981

3. Malignant bone resorption: cellular and biochemical mechanisms;Dodwell;Ann Oncol,1992

4. Cancer and bone;Guise;Endocr Rev,1998

5. Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment;Vinholes;Cancer Treat Rev,1996

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression;Life Science Alliance;2024-09-12

2. Microphysiological systems as models for immunologically ‘cold’ tumors;Frontiers in Cell and Developmental Biology;2024-04-22

3. A potential biomarker of radiosensitivity in metastatic hormone sensitive prostate cancer patients treated with combination external beam radiotherapy and radium-223;Radiotherapy and Oncology;2024-02

4. Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells;Oncology Reports;2024-01-08

5. FOXA1-dependent PUS1 regulates EIF3b stability in a non-enzymatic pathway mediating prostate cancer bone metastasis;International Journal of Biological Sciences;2024